Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA3 | P22001 | 1/20 | 0.58 |
| ▸ | FFAR1 | O14842 | 2/20 | 0.51 |
| ▸ | LTA4H | P09960 | 2/20 | 0.50 |
| ▸ | HTR1B | P28222 | 2/20 | 0.50 |
| ▸ | PKM | P14618 | 2/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | HTT | P42858 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.47 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16479238 | 0.90 | KCNA3 (0.54) | KCNA3LTA4HHTR1BPKMMEN1 | |
| SCHEMBL9913967 | 0.82 | ALDH1A1 (0.47) | PKMMEN1KMT2AL3MBTL1DRD2 | |
| SCHEMBL2227724 | 0.82 | TDP1 (0.52) | FFAR1KMT2A | |
| SCHEMBL15782894 | 0.82 | DRD2 (0.52) | MEN1KMT2AL3MBTL1DRD2DRD4 | |
| SCHEMBL4773566 | 0.81 | DRD4 (0.47) | L3MBTL1DRD2DRD4DRD3 | |
| SCHEMBL3165060 | 0.81 | FFAR1 (0.40) | FFAR1HTTL3MBTL1 | |
| SCHEMBL28499516 | 0.80 | KDM4E (0.56) | HTTL3MBTL1HDAC1DRD3 | |
| SCHEMBL2229091 | 0.80 | TSHR (0.61) | FFAR1KMT2A | |
| SCHEMBL15672741 | 0.80 | DRD2 (0.53) | FFAR1MEN1HTTKMT2AL3MBTL1 | |
| SCHEMBL7728981 | 0.80 | KCNA3 (0.58) | KCNA3LTA4HHTR1BPKML3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-104418801-A | Benzopiperidine-ring and benzomorpholine-ring compound, preparation method and medical application thereof | SHANGHAI RUNNUO BIOTECHNOLOGY CO LTD | 2015-03-18 | — | — | CN | disclosed |
| CN-104321319-A | New indanyloxydihydrobenzofuranylacetic acid derivatives and their use as GPR40 receptor agonists | BOEHRINGER INGELHEIM INT | 2015-01-28 | — | — | CN | disclosed |
| WO-2014086712-A1 | NEW INDANYLOXYDIHYDROBENZOFURANYLACETIC ACIDS | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2014-06-12 | — | — | WO | disclosed |
| US-20030229113-A1 | Keratinocyte growth inhibitors and hydroxamic acid derivatives | AKZO NOBEL N.V. (NL) | 2003-12-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030229113-A1 | Keratinocyte growth inhibitors and hydroxamic acid derivatives | FGF1, FGF2, EGFR | KCNA3 2951/4885FFAR1 1314/4885LTA4H 3637/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.